MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
Regenerative medicine represents one of the most rapidly advancing frontiers in modern healthcare. By leveraging the body’s natural signaling mechanisms, these therapies aim to address the root causes of chronic pain, tissue degradation, and systemic inflammation rather than merely masking symptoms. As patients and families
As regenerative medicine continues to evolve, patients researching stem cell therapies frequently encounter safety questions. A primary concern for many is whether these advanced therapies can trigger adverse long-term effects, specifically abnormal tissue growth (tumors) or internal scarring (fibrosis). To evaluate these risks accurately, it
When considering regenerative medicine, one of the most frequent questions patients ask is: “How long will the results last?” Because every individual possesses a unique physiological makeup, there is no single, universal timeline. The durability of stem cell treatments depends on the type of condition,
In the rapidly evolving landscape of regenerative medicine, patients seeking alternatives to invasive surgeries or chronic symptom management are increasingly encountering the term exosome therapy. Often discussed alongside stem cell treatments, exosomes represent a sophisticated frontier in cellular communication and tissue repair. Understanding what exosomes
Erectile dysfunction (ED) is an incredibly common condition, yet it remains one of the most challenging topics for men to openly discuss. Statistically, the prevalence of ED scales closely with age: approximately 50% of men experience it in their 50s, 60% in their 60s, and
Chronic Obstructive Pulmonary Disease (COPD) remains one of the leading causes of progressive respiratory impairment worldwide. Characterized by chronic inflammation, tissue destruction, and compromised airflow, the condition is managed with traditional strategies that primarily focus on symptom mitigation through bronchodilators, corticosteroids, and supplemental oxygen. However,
If you live with chronic neck, back, knee, or shoulder pain, you’ve likely seen testimonials describing stem cell therapy as a way to avoid surgery and feel “brand new” again. These stories are compelling, but anecdote and evidence aren’t the same thing. This article looks
Professional fighters place extraordinary, repetitive stress on their joints and connective tissue over the course of a career. Chronic knee pain and forearm or elbow overuse injuries often become the deciding factor in how long an athlete can keep competing. That reality has fueled growing
For patients managing multiple chronic illnesses simultaneously, finding an effective path forward can feel overwhelming. When conditions like Sjögren’s syndrome, Lyme disease, and Rocky Mountain spotted fever overlap, the symptom burden — particularly persistent fatigue and cognitive impairment — can significantly diminish quality of life.
iPSCs generate more excitement — and more complex challenges — than almost any other stem cell type being studied today. For patients exploring regenerative medicine, understanding what it is, why it matters, and why it remains unavailable as a treatment is essential. https://www.youtube.com/watch?v=ogcWej42MQ8 What Does
